CN101991723B - A kind of Shiqi exogenous Chinese medicine oral liquid - Google Patents
A kind of Shiqi exogenous Chinese medicine oral liquid Download PDFInfo
- Publication number
- CN101991723B CN101991723B CN201010547777A CN201010547777A CN101991723B CN 101991723 B CN101991723 B CN 101991723B CN 201010547777 A CN201010547777 A CN 201010547777A CN 201010547777 A CN201010547777 A CN 201010547777A CN 101991723 B CN101991723 B CN 101991723B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- oral liquid
- traditional chinese
- pandanus
- jasmine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 239000007788 liquid Substances 0.000 title claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000003937 drug carrier Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 24
- 240000005385 Jasminum sambac Species 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000012153 distilled water Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 235000010408 potassium alginate Nutrition 0.000 claims description 12
- 239000000737 potassium alginate Substances 0.000 claims description 12
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 8
- 239000004302 potassium sorbate Substances 0.000 claims description 8
- 229940069338 potassium sorbate Drugs 0.000 claims description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 210000003608 fece Anatomy 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 4
- 240000002390 Pandanus odoratissimus Species 0.000 claims description 3
- 235000005311 Pandanus odoratissimus Nutrition 0.000 claims description 3
- 102000011759 adducin Human genes 0.000 claims description 2
- 108010076723 adducin Proteins 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims 2
- 244000235630 Prugna di Malabar Species 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 244000087016 Syzygium jambos Species 0.000 abstract description 20
- 235000006647 Eugenia jambos Nutrition 0.000 abstract description 19
- 206010022000 influenza Diseases 0.000 abstract description 9
- 238000012545 processing Methods 0.000 abstract description 2
- 241001438327 Berchemia lineata Species 0.000 abstract 1
- 241000723363 Clerodendrum Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 38
- 235000005308 Pandanus Nutrition 0.000 description 22
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 22
- 239000010931 gold Substances 0.000 description 22
- 229910052737 gold Inorganic materials 0.000 description 22
- 229910052742 iron Inorganic materials 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 241000233930 Pandanus Species 0.000 description 16
- 238000000605 extraction Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 239000008187 granular material Substances 0.000 description 11
- 238000003809 water extraction Methods 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 244000237250 bengkuang Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000019202 steviosides Nutrition 0.000 description 6
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 229940013618 stevioside Drugs 0.000 description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 244000144730 Amygdalus persica Species 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000036071 Rhinorrhea Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 241000531309 Clerodendrum chinense Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- -1 filter Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 235000003930 Aegle marmelos Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241001247852 Berchemia Species 0.000 description 1
- 241000041211 Berchemia floribunda Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 241000284151 Clerodendrum lindleyi Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 235000003470 Ilex asprella Nutrition 0.000 description 1
- 241001100541 Ilex asprella Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000003273 Passiflora laurifolia Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000416918 Polyphylla Species 0.000 description 1
- 235000005138 Spondias dulcis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 229940023462 paste product Drugs 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域 technical field
本发明属于中药学领域,涉及一种中药口服液,具体涉及一种治疗和预防流行性感冒的中药口服液及其制备方法。The invention belongs to the field of traditional Chinese medicine and relates to a traditional Chinese medicine oral liquid, in particular to a traditional Chinese medicine oral liquid for treating and preventing influenza and a preparation method thereof.
背景技术 Background technique
感冒及流行性感冒都是由病毒感染引起的。由于病毒是经由空气传播,因此首当其冲的是鼻子。病毒首先感染鼻黏膜,然后不断繁殖,引致鼻黏膜发炎,出现打喷嚏、流鼻涕、鼻塞等病症。一般的感冒是指鼻感冒,对人体的影响通常只限于呼吸系统。所有症状都与鼻有关,如鼻涕、鼻塞和喉咙痛、咳嗽、甚至发烧等。一般数天后便可痊愈。流行性感冒是由流感病毒引致。流感症状影响全身,包括发热发冷、出汗、全身酸痛、头痛、骨痛、肌肉痛、疲倦乏力、食欲不振、咳嗽、鼻塞等,严重时会引起肺炎及其他并发症,可以致命。流感病毒的特性是有多种类型,每十年左右便会出现新的病毒品种。Both colds and influenza are caused by viral infections. Since the virus is airborne, it is the nose that bears the brunt. The virus first infects the nasal mucosa and then multiplies continuously, causing inflammation of the nasal mucosa and symptoms such as sneezing, runny nose, and nasal congestion. A common cold refers to a nasal cold, which generally affects the human body only on the respiratory system. All symptoms are related to the nose, such as runny nose, stuffy nose and sore throat, cough, and even fever. It usually heals in a few days. Influenza is caused by influenza virus. Influenza symptoms affect the whole body, including fever and chills, sweating, body aches, headache, bone pain, muscle pain, fatigue, loss of appetite, cough, nasal congestion, etc. In severe cases, it can cause pneumonia and other complications, which can be fatal. The nature of influenza viruses is that there are many types, and new virus strains appear every ten years or so.
中医学上并没有病毒这个概念,对于流感或感冒,一律统称为“外邪入侵”,因为病毒发源地不论是鼻黏膜或呼吸道,都属脏腑以外,因此称为“外邪”。中医按病症的表徵和身体反应分类,大致分“风寒感冒”和“风热感冒”。风热感冒症状:喉痛、发烧、没胃口、流鼻涕、有浓痰。风寒感冒症状:畏寒怕风、疲倦、流清鼻水、没有食欲。There is no concept of virus in Chinese medicine. For flu or colds, they are collectively referred to as "exogenous evil invasion". Because the origin of the virus, whether it is the nasal mucous membrane or the respiratory tract, is outside the viscera, it is called "exogenous evil". Traditional Chinese medicine is classified according to symptoms and physical reactions, and can be roughly divided into "wind-cold cold" and "wind-heat cold". Symptoms of anemopyretic cold: sore throat, fever, loss of appetite, runny nose, thick phlegm. Symptoms of anemofrigid and cold: chills and wind, fatigue, runny nose, loss of appetite.
石歧外感茶颗粒,标准编号:WS3-B 2672-97,处方:岗梅铁包金蒲桃臭屎茉莉露兜簕。功能与主治:疏风清热,解暑消食。用于外感引起的发热头痛,食滞饱胀,喉干舌燥,预防流行性感冒。用法与用量:开水冲服,一次10~20g,一日3次。规格:每袋装10g。发明人通过对现有技术的改进,制备一种治疗和预防流行性感冒的中药口服液。Shiqi external sensation tea granules, standard number: WS3-B 2672-97, prescription: Gangmei iron-wrapped golden apple peach stinky feces jasmine pandanus. Functions and indications: Dispelling wind and clearing heat, relieving summer heat and eliminating food. It is used for fever and headache caused by exogenous pathogenic factors, stagnation of food, fullness, dry throat, and prevention of influenza. Usage and dosage: Take after boiling water, 10-20g each time, 3 times a day. Specifications: 10g per bag. The inventor prepared a traditional Chinese medicine oral liquid for treating and preventing influenza by improving the prior art.
石歧外感茶颗粒的中药原料,其来源于:The traditional Chinese medicine raw materials of Shiqi Waigan tea granules are derived from:
露兜簕:露兜树Pandanus tectorius Sol.及其近缘种;Pandanus: Pandanus tectorius Sol. and its relatives;
铁包金:铁包金Berchemia lineate(Linn.)DC.、多花勾儿茶Berchemia floribunda(Wall.)Brongn.、光枝勾儿茶Berchemia polyphylla wall.ex Laws.Var.leiocladaHand.-Mazz.及其近缘种;Iron-clad gold: Iron-clad gold Berchemia lineate (Linn.) DC., Berchemia floribunda (Wall.) Brongn., Bechemia polyphylla wall.ex Laws.Var.leiocladaHand.-Mazz. and closely related species
蒲桃:蒲桃Syzygium jambos(Linn.)Alston及其近缘种;Rose apple: Rose apple Syzygium jambos (Linn.) Alston and its relatives;
岗梅:梅叶冬青Ilex asprella(Hook.et Arn.)Champ.ex Benth及其近缘种;Gangmei: Ilex asprella (Hook.et Arn.) Champ.ex Benth and its relatives;
臭屎茉莉:尖齿臭茉莉Clerodendrum lindleyi Decne.ex Planch.、重瓣臭茉莉Clerodendrum philippinum Schauer、臭茉莉Clerodendrum philippinum Schauer var.simplex Moldenke及其近缘种;Smelly jasmine: Clerodendrum lindleyi Decne.ex Planch., Clerodendrum philippinum Schauer, Clerodendrum philippinum Schauer var.simplex Moldenke and their relatives;
尽管石歧外感茶颗粒已经上市多年,但是患者对其效果并不满意,主要原因存在几点:其口感不好;服用不便,需要开水冲服;稳定性不好,贮存时间短;检测方法不准确,不能保证药品质量。另外,由于中药成分复杂,提取工艺相对落后,制备中易出现吸湿、流动性差、难崩解等常见问题,通过加入适宜的辅料,改进工艺,可提高中药的质量及疗效,并提高生产效率。Although Shiqi Waigan tea granule has been on the market for many years, patients are not satisfied with its effect. The main reasons are: its taste is not good; it is inconvenient to take, it needs to be taken with boiled water; the stability is not good, the storage time is short; the detection method is not accurate , cannot guarantee the quality of medicines. In addition, due to the complex ingredients of traditional Chinese medicine, the extraction process is relatively backward, and common problems such as moisture absorption, poor fluidity, and difficulty in disintegration are prone to occur during preparation. By adding appropriate excipients and improving the process, the quality and curative effect of traditional Chinese medicine can be improved, and production efficiency can be improved.
本发明的发明人根据中医理论,并且通过不断的科学实验,对配方和制备方法进行了筛选,有效的解决上了上述问题。According to the theory of traditional Chinese medicine, the inventor of the present invention screened the formula and preparation method through continuous scientific experiments, and effectively solved the above-mentioned problems.
发明内容 Contents of the invention
本发明的目的在于提供一种治疗和预防流行性感冒的中药口服液。The object of the present invention is to provide a kind of traditional Chinese medicine oral liquid for treating and preventing influenza.
本发明所述的中药口服液由以下中药原料药和药学上可接受的载体加工制成:Chinese medicine oral liquid of the present invention is processed by following Chinese medicine raw material and pharmaceutically acceptable carrier:
岗梅245-980g 铁包金245-980g 蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g
臭屎茉莉98-392g 露兜簕245-980gSmelly jasmine 98-392g Pandanus 245-980g
以上组成中,药的重量是以生药计算的,以重量作为配比,在生产时可按照比例增大或减少,如大规模生产可以以公斤为单位,或以吨为单位,小规模生产也可以以克或毫克为单位,重量可以增大或者减小,但各组成之间的生药材重量配比的比例不变。In the above composition, the weight of the medicine is calculated based on the crude drug, and the weight is used as the proportion, which can be increased or decreased according to the proportion during production. For example, the unit of kilogram or ton can be used for large-scale production, and the unit of small-scale production can also be The unit can be gram or milligram, and the weight can be increased or decreased, but the weight ratio of the raw medicinal materials among the components remains unchanged.
以上重量配比的比例是经过科学筛选得到的,对于特殊病人,如重症或轻症,肥胖或瘦小的病人,可以相应调整组成的量的配比,增加或减少不超过100%,药效不变。The proportion of the above weight ratio is obtained through scientific screening. For special patients, such as severe or mild, obese or thin patients, the proportion of the composition can be adjusted accordingly, and the increase or decrease does not exceed 100%. Change.
以上组成可以制成本发明的口服液1000ml。The above composition can be made into 1000ml of oral liquid of the present invention.
优选的,本发明所述的中药口服液由以下中药原料药和药学上可接受的载体加工制成:Preferably, the traditional Chinese medicine oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:
岗梅245-980g 铁包金245-980g 蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g
臭屎茉莉98-392g 露兜簕245-980g 矫味剂2-100gSmelly jasmine 98-392g Pandanus 245-980g Flavoring agent 2-100g
抑菌剂1-4g 增稠剂1.5-6g 蒸馏水10-1000mlBacteriostat 1-4g Thickener 1.5-6g Distilled water 10-1000ml
其中,所述抑菌剂包括但不仅限于山梨酸钾、苯酚、壳聚糖、101果汁澄清剂、ZTC1+1、乙醇等。Wherein, the bacteriostatic agent includes but not limited to potassium sorbate, phenol, chitosan, 101 fruit juice clarifier, ZTC1+1, ethanol and the like.
其中,所述矫味剂包括但不仅限于蔗糖、甘露醇、木糖醇、甜菊糖甙、乳糖、果糖、蔗糖、蛋白糖、麦芽糖醇、甘草甜素、环己氨基磺酸钠、明胶、阿斯巴甜、香蕉香精、菠萝香精、香兰素、香橙香精、桔子香精、薄荷香精、人参香精、枸椽酸、柠檬酸等,可单独使用,也可组合使用。Wherein, the flavoring agent includes but not limited to sucrose, mannitol, xylitol, steviol glycoside, lactose, fructose, sucrose, protein sugar, maltitol, glycyrrhizin, sodium cyclamate, gelatin, Spartame, banana flavor, pineapple flavor, vanillin, orange flavor, orange flavor, mint flavor, ginseng flavor, citric acid, citric acid, etc. can be used alone or in combination.
其中,所述增稠剂包括但不仅限于海藻酸钾、淀粉、果胶、琼脂、明胶、海藻脂、角叉胶、糊精、黄耆胶、多糖素衍生物。Wherein, the thickener includes but not limited to potassium alginate, starch, pectin, agar, gelatin, algae fat, carrageenan, dextrin, tragacanth gum, and polysaccharide derivatives.
进一步优选的,本发明所述的口服液由以下中药原料药和药学上可接受的载体加工制成:Further preferably, the oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:
岗梅245-980g 铁包金245-980g 蒲桃245-980gGangmei 245-980g Iron clad gold 245-980g Rose apple 245-980g
臭屎茉莉98-392g 露兜簕245-980g 蔗糖2-100gSmelly jasmine 98-392g Pandanus 245-980g Sucrose 2-100g
山梨酸钾1-4g 海藻酸钾1.5-6g 蒸馏水10-1000ml。Potassium sorbate 1-4g Potassium alginate 1.5-6g Distilled water 10-1000ml.
更加优选的,本发明所述的口服液由以下中药原料药和药学上可接受的载体加工制成:More preferably, the oral liquid of the present invention is processed from the following traditional Chinese medicine raw materials and pharmaceutically acceptable carriers:
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g
山梨酸钾2g 海藻酸钾3g 蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.
本发明其他优选的配方组成在实施例中。Other preferred formulations of the present invention are included in the examples.
本发明的另一个目的在于提供本发明所述口服液的制备方法。Another object of the present invention is to provide the preparation method of the oral liquid of the present invention.
本发明所述的口服液的制备方法,包括以下步骤:The preparation method of oral liquid of the present invention comprises the following steps:
本发明的中药制剂,是通过将上述配方组成的中药原料经过提取或其他方式加工,取以上岗梅490g,铁包金490g,蒲桃490g,臭屎茉莉196g,露兜簕490g,加水煎煮二次,每次2小时,每次加水量为药材量的6倍,合并提取液,滤过,滤液浓缩稠膏状,加上述辅料,混合制成1000ml。The traditional Chinese medicine preparation of the present invention is obtained by extracting or processing the raw materials of traditional Chinese medicine composed of the above formula, taking 490g of Shanggangmei, 490g of iron-clad gold, 490g of rose apple, 196g of jasmine, and 490g of pandanus, and decocting them with water. The second time, 2 hours each time, the amount of water added each time is 6 times the amount of medicinal materials, the extracts are combined, filtered, the filtrate is concentrated into a thick paste, the above-mentioned auxiliary materials are added, and mixed to make 1000ml.
本发明的特殊之处在于对已有制备工艺进行了改进,将水煮改为水煮醇沉,工艺步骤为:取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加水煎煮二次,每次2小时,每次加水量为药材量的6倍,合并提取液,浓缩到相对密度为1.10~1.15(50~60℃),加95%的药用乙醇使溶液含醇量到60-70%,放置12-24小时,过滤,滤液浓缩,干燥,粉碎成细粉,加辅料,混合制成1000ml。The special feature of the present invention is that the existing preparation process has been improved, and water boiling is changed to water boiling and alcohol precipitation. The process steps are: take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus , add water and decoct twice, each time for 2 hours, the amount of water added each time is 6 times the amount of medicinal materials, the combined extracts are concentrated to a relative density of 1.10 to 1.15 (50 to 60 ° C), and 95% medicinal ethanol is added for use. The solution has an alcohol content of 60-70%, standing for 12-24 hours, filtering, concentrating the filtrate, drying, pulverizing into fine powder, adding auxiliary materials, and mixing to make 1000ml.
水提工艺提出的非药用成份较多,水提工艺含量差异性大且吸湿性大;会干扰了药品质量标准的检测,不能准确控制药品质量,工艺不稳定;水提醇沉工艺的样品鉴别项均能检出,有效成分含量较高,含量的差异性小,表明醇沉后的工艺稳定性好。There are many non-medicinal ingredients proposed by the water extraction process, the content of the water extraction process is highly variable and hygroscopic; it will interfere with the detection of drug quality standards, the quality of the drug cannot be accurately controlled, and the process is unstable; the samples of the water extraction and alcohol precipitation process All identification items can be detected, the content of active ingredients is high, and the difference in content is small, indicating that the process stability after alcohol precipitation is good.
本发明另一优选的改进是将水煮改为酒提,所述制备方法包括以下步骤:Another preferred improvement of the present invention is to change boiling to wine extraction, and the preparation method includes the following steps:
取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加95%乙醇回流提取二次,合并提取液,滤过,滤液浓缩至无醇味,得到稠膏状产物,加辅料混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose apple, stinky jasmine and pandanus, add 95% ethanol for reflux extraction twice, combine the extracts, filter, and concentrate the filtrate until it has no alcohol smell, and obtain a thick paste product. Add auxiliary materials and mix to make 1000ml.
本发明所述口服液有效的改善了不良口味,增加了病人服药顺应性。由于制剂处方口味优良,提高了产品的内在价值,这种制剂在同类产品竞争中会占据一定的优势,本发明的口服液适合各个年龄段的人群使用,尤其是在儿科用药时,口味易于小儿接受,增加临床使用范围。另外,本发明还有效的提高了口服液的澄清度,解决了中药口服液放置一段时间后容易产生沉淀的问题。The oral liquid of the invention can effectively improve the bad taste and increase the patient's medication compliance. Due to the excellent taste of the preparation prescription, which improves the intrinsic value of the product, this preparation will occupy a certain advantage in the competition of similar products. The oral liquid of the present invention is suitable for use by people of all ages, especially when it is used in pediatrics, the taste is easy for children. Accepted, increase the scope of clinical use. In addition, the invention also effectively improves the clarity of the oral liquid, and solves the problem that the traditional Chinese medicine oral liquid is prone to precipitation after being placed for a period of time.
本发明的口服液与现有技术相比较,还具有治疗效果好,副作用少,见效快,口感好,药品保质期长,稳定性好,成本低,制备工艺更加简单,节省了制备药物的时间等诸多优点。Compared with the prior art, the oral liquid of the present invention also has the advantages of good therapeutic effect, few side effects, quick effect, good taste, long drug shelf life, good stability, low cost, simpler preparation process, and saves time for preparing drugs, etc. Many advantages.
具体实施方式 Detailed ways
通过以下具体实施例对本发明作进一步说明,但不作为对本发明的限制。The present invention will be further illustrated by the following specific examples, but not as a limitation of the present invention.
实施例1、口服液Embodiment 1, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g
山梨酸钾2g 海藻酸钾3g 蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.
取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,加水煎煮二次,每次24小时,每次加水量为药材量的6倍,合并提取液,浓缩,加95%的药用乙醇是溶液含醇量到70%,放置24小时,过滤,滤液浓缩,干燥,粉碎成细粉,加辅料,混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus, add water to decoct twice, 24 hours each time, add 6 times the amount of medicinal materials each time, combine the extracts, concentrate, add The 95% medicinal ethanol is that the solution contains 70% alcohol, put it aside for 24 hours, filter, concentrate the filtrate, dry, pulverize into fine powder, add auxiliary materials, and mix to make 1000ml.
实施例2、口服液Embodiment 2, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 蔗糖50gStinking jasmine 196g Pandanus 490g Sucrose 50g
山梨酸钾2g 海藻酸钾3g 蒸馏水到1000ml。Potassium sorbate 2g Potassium alginate 3g Distilled water to 1000ml.
取以上五味岗梅,铁包金,蒲桃,臭屎茉莉和露兜簕,用95%乙醇回流提取2次,第一次加10倍量,回流提取2小时,过滤,药渣第二次加8倍量,回流提取1小时,过滤,合并滤液,减压回收乙醇至无醇味,合并提取液,滤过,滤液浓缩至密度为1.15-1.20(60℃热测)稠膏状,加辅料混合制成1000ml。Take the above five-flavored plum, iron-coated gold, rose peach, stinky jasmine and pandanus, and use 95% ethanol to reflux extract twice, add 10 times the amount for the first time, reflux extraction for 2 hours, filter, and dregs for the second time Add 8 times the amount, reflux extraction for 1 hour, filter, combine the filtrates, recover ethanol under reduced pressure until there is no alcohol smell, combine the extracts, filter, and concentrate the filtrate to a thick paste with a density of 1.15-1.20 (60°C thermal measurement), add The auxiliary materials are mixed to make 1000ml.
实施例3、综合疗效评价:Embodiment 3, comprehensive curative effect evaluation:
试验组:本发明实施例1,2的口服液;Test group: the oral liquid of embodiment 1 and 2 of the present invention;
现有颗粒剂对照组:石岐外感颗粒,中山市恒生药业有限公司生产,国药准字Z44020184。规格:每袋装10g,批号:20071201,Existing granule control group: Shiqi Waigan Granules, produced by Zhongshan Hengsheng Pharmaceutical Co., Ltd., Z44020184. Specifications: 10g per bag, batch number: 20071201,
方法:采用随机盲法、阳性药平行对照。METHODS: Random blind method and positive drug parallel control were adopted.
疗程:3天。Course of treatment: 3 days.
给药方案:(1)试验组:一次1瓶(10ml/瓶),一日3次;(2)对照组:一次2袋,一日3次。Dosing regimen: (1) Test group: 1 bottle (10ml/bottle) each time, 3 times a day; (2) Control group: 2 bags each time, 3 times a day.
试验结果如下:The test results are as follows:
综合疗效评定标准Comprehensive curative effect evaluation standard
痊愈:治疗3天以内体温恢复正常,感冒的症状和体征积分下降≥90%;Recovery: within 3 days of treatment, the body temperature returned to normal, and the symptoms and signs of colds decreased by ≥90%;
显效:治疗3天以内体温正常,感冒的症状和体征积分下降≥70%、<90%;Significantly effective: within 3 days of treatment, the body temperature is normal, and the symptoms and signs of colds are reduced by ≥70%, <90%;
有效:治疗3天以内体温较前降低,感冒症状和体征积分下降≥30%、<70%;Effective: within 3 days of treatment, the body temperature is lower than before, and the score of cold symptoms and signs is reduced by ≥30%, <70%;
无效:治疗3天以内体温未降或升高,感冒的症状和体征积分<30%。Ineffective: The body temperature did not drop or rise within 3 days of treatment, and the symptoms and signs of colds were less than 30%.
中医感冒风热证综合疗效评价:试验组(本发明实施例1)有效率90.17%;(本发明实施例2)有效率87.96%;现有颗粒剂对照组有效率85.21%。Comprehensive curative effect evaluation of TCM syndrome of cold and wind-heat: the effective rate of the test group (Example 1 of the present invention) is 90.17%; (Example 2 of the present invention) effective rate is 87.96%;
中医感冒暑湿证综合疗效评价:试验组(本发明实施例1)有效率91.45%;(本发明实施例2)有效率89.27%;现有颗粒剂对照组有效率83.17%。Comprehensive curative effect evaluation of TCM syndrome of common cold and heat-dampness: the effective rate of the test group (Example 1 of the present invention) is 91.45%; the effective rate of (Example 2 of the present invention) is 89.27%; the effective rate of the existing granule control group is 83.17%.
中医证候疗效判定标准Criteria for judging curative effect of TCM syndromes
疗效指数计算公式为(n)=(治疗前总积分-治疗后总积分)/治疗前总积分×100%(尼莫地平法)The formula for calculating curative effect index is (n)=(total score before treatment-total score after treatment)/total score before treatment×100% (nimodipine method)
临床痊愈:疗效指数(积分值降低)≥95%;Clinical recovery: curative effect index (integral value reduction) ≥ 95%;
显效:70%≤疗效指数(积分值降低)<95%;Markedly effective: 70% ≤ curative effect index (integral value reduction) < 95%;
有效:30%≤疗效指数(积分值降低)<70%;Effective: 30% ≤ curative effect index (integral value reduction) < 70%;
无效:疗效指数(积分值降低)<30%。Ineffective: curative effect index (decrease in integral value) <30%.
中医感冒风热证证候疗效评价:试验组(本发明实施例1)有效率89.45%;(本发明实施例2)有效率89.66%;现有颗粒剂对照组有效率87.37%。Evaluation of the curative effect of traditional Chinese medicine cold and wind-heat syndrome: the effective rate of the test group (the embodiment 1 of the present invention) is 89.45%; the effective rate of (the embodiment 2 of the present invention) is 89.66%;
中医感冒暑湿证证候疗效评价:试验组(本发明实施例1)有效率93.27%;(本发明实施例2)有效率89.22%;现有颗粒剂对照组有效率88.07%。Evaluation of the curative effect of TCM cold and heat-dampness syndrome: the effective rate of the test group (Example 1 of the present invention) is 93.27%; (Example 2 of the present invention) effective rate is 89.22%; the effective rate of the existing granule control group is 88.07%.
退热疗效判定标准Criteria for Judgment of Antipyretic Efficacy
痊愈:治疗24小时内,体温恢复正常,且无反复;Recovery: within 24 hours of treatment, the body temperature returned to normal without recurrence;
显效:治疗24小时内,体温降低≥1.0℃以上,但未至正常;Significantly effective: within 24 hours of treatment, the body temperature drops ≥ 1.0°C, but not to normal;
有效:治疗24小时内,体温降低>0.5<1.0℃,但未至正常;Effective: Within 24 hours of treatment, the body temperature decreased by >0.5<1.0°C, but not to normal;
无效:治疗24小时内,体温降低不足0.5℃。Ineffective: within 24 hours of treatment, the temperature drop is less than 0.5°C.
退热疗效(24小时)与退热起效时间比较Comparison of antipyretic efficacy (24 hours) and antipyretic onset time
风热感冒比较:试验组(本发明实施例1)退热疗效(24小时)有效率83.78%;(本发明实施例2)有效率78.28%;现有颗粒剂对照组有效率75.27%。Anemopyretic cold comparison: test group (the embodiment of the present invention 1) antipyretic curative effect (24 hours) effective rate 83.78%; (the present invention 2) effective rate 78.28%; Existing granule control group effective rate 75.27%.
暑湿感冒比较:试验组(本发明实施例1)退热疗效(24小时)有效率81.25%;(本发明实施例2)有效率80.52%,现有颗粒剂对照组有效率76.85%。Shushi cold comparison: test group (embodiment 1 of the present invention) antipyretic curative effect (24 hours) effective rate 81.25%; (embodiment 2 of the present invention) effective rate 80.52%, existing granule control group effective rate 76.85%.
单项症状疗效评价:Efficacy evaluation of individual symptoms:
头痛:试验组(本发明实施例1)有效率90.24%;(本发明实施例2)有效率88.56%,现有颗粒剂对照组有效率86.10%。Headache: the effective rate of the test group (Example 1 of the present invention) is 90.24%; the effective rate of (Example 2 of the present invention) is 88.56%, and the effective rate of the existing granule control group is 86.10%.
恶心:试验组(本发明实施例1)有效率96.25%;(本发明实施例2)有效率80.87%,现有颗粒剂对照组有效率89.38%。Nausea: the effective rate of the test group (Example 1 of the present invention) is 96.25%; the effective rate of (Example 2 of the present invention) is 80.87%, and the effective rate of the existing granule control group is 89.38%.
安全性评价:本发明实施例1的药物在治疗前后检查了血、尿、便常规、肝功能、肾功能和心电图,根据试验前后安全性指标检测结果,未发现新增实验室检查指标异常情况出现。Safety evaluation: The drug of Example 1 of the present invention has been checked for blood, urine, stool routine, liver function, kidney function and electrocardiogram before and after treatment. According to the test results of safety indicators before and after the test, no abnormalities in newly added laboratory inspection indicators were found. Appear.
实施例4、口服液Embodiment 4, oral liquid
岗梅245g 铁包金245g 蒲桃245gGangmei 245g Iron clad gold 245g Rose apple 245g
臭屎茉莉98g 露兜簕245g 蔗糖2gSmelly jasmine 98g Pandanus 245g Sucrose 2g
山梨酸钾1g 海藻酸钾1.5g 蒸馏水到1000ml。Potassium sorbate 1g Potassium alginate 1.5g Distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例5、口服液Embodiment 5, oral liquid
岗梅2980g 铁包金980g 蒲桃980gGangmei 2980g Iron clad gold 980g Rose apple 980g
臭屎茉莉392g 露兜簕980g 蔗糖100gStinking jasmine 392g Pandanus 980g Sucrose 100g
山梨酸钾4g 海藻酸钾6g 蒸馏水到1000ml。Potassium sorbate 4g Potassium alginate 6g Distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例12、口服液Embodiment 12, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 甜菊糖甙2.5gStinking jasmine 196g Pandanus 490g Stevioside 2.5g
苯酚1.5g 海藻酸钾4g 蒸馏水到1000ml。Phenol 1.5g Potassium alginate 4g Distilled water to 1000ml.
实施例6、口服液Embodiment 6, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 甜菊糖甙4gStinking jasmine 196g Pandanus 490g Stevioside 4g
苯酚2g 琼脂3g 蒸馏水到1000mlphenol 2g agar 3g distilled water to 1000ml
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例7、口服液Embodiment 7, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 木糖醇4gSmelly feces jasmine 196g Pandanus 490g Xylitol 4g
ZTC1+1 2g 琼脂3g 蒸馏水到1000ml。ZTC1+1 2g agar 3g distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例8、口服液Embodiment 8, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 木糖醇4gSmelly feces jasmine 196g Pandanus 490g Xylitol 4g
ZTC1+1 2g 糊精3g 蒸馏水到1000ml。ZTC1+1 2g dextrin 3g distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例9、口服液Embodiment 9, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 甜菊糖甙2gStinking jasmine 196g Pandanus 490g Stevioside 2g
壳聚糖1g 海藻酸钾1.5g 蒸馏水到1000ml。Chitosan 1g Potassium alginate 1.5g Distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例10、口服液Embodiment 10, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 甜菊糖甙8gStinking jasmine 196g Pandanus 490g Stevioside 8g
壳聚糖4g 海藻酸钾6g 蒸馏水到1000ml。Chitosan 4g Potassium alginate 6g Distilled water to 1000ml.
制备方法选用上述的醇提或者水提。The preparation method selects the above-mentioned alcohol extraction or water extraction.
实施例11、口服液Embodiment 11, oral liquid
岗梅490g 铁包金490g 蒲桃490gGangmei 490g Iron clad gold 490g Rose apple 490g
臭屎茉莉196g 露兜簕490g 甜菊糖甙6gStinking jasmine 196g Pandanus 490g Stevioside 6g
壳聚糖2g 海藻酸钾5g 蒸馏水到1000ml。Chitosan 2g Potassium alginate 5g Distilled water to 1000ml.
Claims (1)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010547777A CN101991723B (en) | 2010-11-12 | 2010-11-12 | A kind of Shiqi exogenous Chinese medicine oral liquid |
| HK11107207.1A HK1153132B (en) | 2011-07-12 | A kind of chinese medicinal oral liquid from shiqi against exogenous infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010547777A CN101991723B (en) | 2010-11-12 | 2010-11-12 | A kind of Shiqi exogenous Chinese medicine oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101991723A CN101991723A (en) | 2011-03-30 |
| CN101991723B true CN101991723B (en) | 2012-09-05 |
Family
ID=43782799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010547777A Expired - Fee Related CN101991723B (en) | 2010-11-12 | 2010-11-12 | A kind of Shiqi exogenous Chinese medicine oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991723B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105879432A (en) * | 2015-01-18 | 2016-08-24 | 广东省中医院 | Method for clarifying Chinese herbal preparation for treating psoriasis |
-
2010
- 2010-11-12 CN CN201010547777A patent/CN101991723B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中华人民共和国卫生部药典委员会.石歧外感茶颗粒.《中华人民共和国卫生部药品标准中药成方制剂第十四册》.1997,26. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101991723A (en) | 2011-03-30 |
| HK1153132A1 (en) | 2012-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102188575B (en) | Oral liquid preparation for treating infantile indigestion with food retention and cough and preparation method thereof | |
| CN108310124B (en) | A kind of oral liquid for clearing lung heat and preparation method thereof | |
| CN101991723B (en) | A kind of Shiqi exogenous Chinese medicine oral liquid | |
| CN116941700B (en) | Throat-clearing and throat-moistening candy rich in vitamin C and preparation method thereof | |
| CN102772663A (en) | Orally-taken medicine for preventing and treating infantile asthma and preparation method thereof | |
| CN102178792B (en) | Shiqi exogenous traditional Chinese medicine buccal tablet | |
| CN107625828A (en) | A kind of health protection tea for auxiliary treatment chronic pharyngitis, preparation method and application | |
| CN104840737B (en) | Chinese medicine composition with qi invigorating and lung moistening effect and its preparation method and application | |
| CN102973657B (en) | Cough-relieving Qinbaohong mixture and preparation method thereof | |
| CN101983669B (en) | Shiqi exogenous traditional Chinese medicine syrup | |
| CN101991722B (en) | Shiqi exogenous traditional Chinese medicine capsule | |
| CN101711823B (en) | Medicines used to treat asthmatic bronchitis | |
| CN101983667B (en) | A kind of traditional Chinese medicine drink with exogenous Shiqi | |
| CN106913516A (en) | A kind of blue syrup in Pu ground and its production and use | |
| CN101991721A (en) | A kind of sugar-free granule of Shiqi exogenous traditional Chinese medicine | |
| CN110179855A (en) | A kind of therapeutic agent and its formulation preparation method of post-natal depression | |
| CN116211993B (en) | Composition for treating senile chronic disease and its preparation method | |
| CN103623203B (en) | A kind of preparation method of dimethoxanate oral formulations | |
| CN108030887A (en) | A kind of Chinese materia medica syrup for being used to treat cough variant asthma in childhood: prednison comparing | |
| CN107596107B (en) | Heat-clearing, sore-throat-relieving and anti-allergic traditional Chinese medicine preparation and preparation method thereof | |
| HK1153132B (en) | A kind of chinese medicinal oral liquid from shiqi against exogenous infection | |
| CN111870654A (en) | Traditional Chinese medicine compound for preventing and treating recurrent respiratory tract infection of children | |
| CN104840795A (en) | Traditional Chinese medicine composition for treating infantile dry cough | |
| CN115089689A (en) | Traditional Chinese medicine composition for treating spasmodic cough and preparation method and application thereof | |
| CN116870078A (en) | Traditional Chinese medicine composition for treating influenza and method, composition particles and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1153132 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1153132 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 Termination date: 20171112 |